25 results match your criteria: "Lansi-Pohja Central Hospital[Affiliation]"
Eur J Haematol
January 2025
Institute of Clinical Medicine, Oncology, University of Eastern Finland, Kuopio, Finland.
Purpose: The prognosis of relapsed primary central nervous system lymphoma remains a concern. This study aimed to compare the effects of various patient- and disease-related factors on the prognosis of relapsed primary central nervous system lymphoma (PCNSL).
Methods: We retrospectively collected real-world data from eight Finnish hospitals on 198 patients diagnosed with PCNSL between 2003 and 2020.
Biomed Pharmacother
January 2025
Medical Research Center, Oulu University Hospital, Oulu, Finland; Department of Internal Medicine, Länsi-Pohja Central Hospital, Kemi, Finland; Biomedicine and Internal Medicine Research Unit, University of Oulu, Oulu, Finland.
It has been demonstrated that diffuse large B-cell lymphoma (DLBCL) is especially sensitive to ferroptosis. Currently, confirming the presence of ferroptosis requires flow cytometry, which is a time consuming and labor-intensive task. Blistering of the cell membrane has been shown to be a ferroptosis-specific morphological change.
View Article and Find Full Text PDFAnn Hematol
December 2024
Department of Oncology, Kuopio University Hospital, Kuopio, Finland.
Background: The optimal follow-up protocol for primary central nervous system lymphoma (PCNSL) is unclear. This is the first study to evaluate the benefit of structured follow-up imaging of PCNSL with respect to the timing of relapse.
Methods: A total of 198 PCNSL patients (57.
Anticancer Res
November 2024
Cancer Research and Translational Medicine Research Unit, University of Oulu, Oulu, Finland.
J Invest Dermatol
September 2024
Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
Hematol Rep
August 2024
Cancer and Translational Research Unit, University of Oulu, 90220 Oulu, Finland.
The present study provides real-world evidence on the treatment of multiple myeloma (MM) bone disease with various bisphosphonates combined for different myeloma-specific treatments as no validated data regarding the best combination treatment for bone disease associated with MM are available. We examined retrospectively 345 MM patients treated with autologous stem cell transplantation in Finland during 1996-2020. The median age of the patients was 60 years with a median follow-up time of 50 months (1-339).
View Article and Find Full Text PDFAnticancer Res
August 2024
Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland.
Background/aim: Central nervous system (CNS) involvement in aggressive B-cell lymphoma, either as a primary or secondary event to systemic disease, portends a poor prognosis. This study sought to identify patients at high risk for CNS relapse by analyzing their human leukocyte antigen (HLA) genotypes.
Patients And Methods: We retrospectively examined the HLA genotypes of 164 patients with systemic lymphoma, primary CNS lymphoma, and CNS relapse of systemic lymphoma.
Acta Oncol
May 2024
Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland; Medical Research Center, Oulu University Hospital and Translational Medicine Research Unit, University of Oulu, Oulu, Finland; Department of Oncology, Kuopio University Hospital, Kuopio, Finland.
Background: The modern-day therapeutic landscape for follicular lymphoma (FL) includes a number of highly effective therapies.
Patients And Methods: We set out to determine progression-free survival (PFS) after front line, second line, and third line of therapy on the basis of relevant biological characteristics and therapeutic choices. Patients (n = 743, 51% females, median 60 years old) diagnosed with grade 1-2 FL between 1997 and 2016 in nine institutions were included.
Cancer Med
January 2024
Faculty of Health Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Background: Rituximab-based combinations are the standard of care in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Despite being on market for over 20 years, some of the adverse effects associated with the use of rituximab are not well known. Drug-induced interstitial pneumonitis (DIP) is a potentially fatal complication of the treatment.
View Article and Find Full Text PDFEur J Surg Oncol
July 2022
Surgery Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland; Upper Gastointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Purpose: To examine the annual hospital volume of surgery in relation to survival in colorectal cancer. Previous studies on hospital volume and survival following colorectal cancer surgery are conflicting.
Methods: All 49 032 patients who underwent resection for colorectal cancer in 1987-2016 in Finland were included, with complete follow-up until December 31, 2019.
Ann Hematol
December 2019
Comprehensive Cancer Center, Department of Hematology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Autologous stem cell transplantation (ASCT) combined with novel agents is the standard treatment for transplant-eligible, newly diagnosed myeloma (NDMM) patients. Lenalidomide is approved for maintenance after ASCT until progression, although the optimal duration of maintenance is unknown. In this trial, 80 patients with NDMM received three cycles of lenalidomide, bortezomib, and dexamethasone followed by ASCT and lenalidomide maintenance until progression or toxicity.
View Article and Find Full Text PDFEuro Surveill
September 2019
Department of Health Security, National Institute for Health and Welfare, Helsinki, Finland.
BackgroundTwo epidemiologically-unrelated clusters of carbapenemase (KPC)-producing were detected among several healthcare facilities (HCF) in Finland by routine surveillance using whole genome sequencing (WGS).AimThe objective was to investigate transmission chains to stop further spread of the responsible strain.MethodsIn this observational retrospective study, cases were defined as patients with KPC-3 sequence type (ST)512 strain detected in Finland from August 2013 to May 2018.
View Article and Find Full Text PDFScand J Trauma Resusc Emerg Med
February 2019
FinnHEMS Research and Development Unit, Vantaa, Finland.
Background: A high number of denied or cancelled HEMS missions are caused by poor weather conditions especially during winter season. Furthermore, many helicopter manufacturers have denied their helicopters to be operated in known icing conditions. Icing is a widely known phenomenon in aviation, but there is a lack of evidence about its influence on HEMS operations and patients.
View Article and Find Full Text PDFJ Dent Child (Chic)
May 2018
Department of Oral and Maxillofacial Surgery, Oulu University Hospital and Department of Periodontology and Geriatric Dentistry, Unit of Oral Health Sciences, University of Oulu, Oulu, Finland.
Orofacial granulomatosis (OFG) is a chronic inflammatory disorder characterized by lip swelling and gingival alterations. OFG occurs either as a separate clinical entity or associated with a systemic disorder such as Crohn's disease (CD). The purpose of this paper is to report the case of a 13-year old boy who presented with marked granulomatous gingival inflammation and stomach discomfort.
View Article and Find Full Text PDFAm J Hum Genet
April 2016
Neuroscience Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA. Electronic address:
Deficits in the basal ganglia pathways modulating cortical motor activity underlie both Parkinson disease (PD) and Huntington disease (HD). Phosphodiesterase 10A (PDE10A) is enriched in the striatum, and animal data suggest that it is a key regulator of this circuitry. Here, we report on germline PDE10A mutations in eight individuals from two families affected by a hyperkinetic movement disorder due to homozygous mutations c.
View Article and Find Full Text PDFBone Marrow Transplant
March 2016
Department of Medicine, Kuopio University Hospital, Kuopio, Finland.
The most common means of mobilizing autologous stem cells is G-CSF alone or combined with cyclophosphamide (CY) to obtain sufficient CD34+ cells for one to two transplants. There are few prospective, randomized studies investigating mobilization regimens in multiple myeloma (MM), especially after lenalidomide-based induction. We designed this prospective, randomized study to compare low-dose CY 2 g/m2 +G-CSF (arm A) and G-CSF alone (arm B) after lenalidomide-based up-front induction in MM.
View Article and Find Full Text PDFEur J Paediatr Neurol
November 2015
Department of Pediatric Neurology, Children's Hospital, University of Helsinki, PO Box 280, 00029 HUS, Helsinki, Finland. Electronic address:
Background: Dose regimens of pyridoxine (vitamin B6) for treatment of infantile spasms have varied from 200 mg/d to 300 mg/kg/d. Only two long-term outcome studies of the treated patients are available.
Methods: We asked all pediatric neurologists treating pediatric epilepsy in Finland if they had seen patients with pyridoxine-responsive infantile epilepsy.
APMIS
September 2010
Länsi-Pohja Central Hospital, Kemi, Finland.
We investigated the expression of claudins 1, 3-7 and transcriptional factor twist in a set of testicular germ cell tumors. The material consisted of 17 seminomas, 13 teratomas, 9 teratocarcinomas, 20 embryonal carcinomas and 9 mixed germ cell tumors. They were immunostained with antibodies to claudins 1, 3-7 and twist.
View Article and Find Full Text PDFArch Gynecol Obstet
May 2011
Department of Obstetrics and Gynecology, Länsi-Pohja Central Hospital, Kemi, Finland.
Purpose: The aim of this study was to determine whether benign joint hypermobility (BJH) is associated with urogenital prolapse and altered collagen metabolism.
Methods: 43 postmenopausal women with previous vaginal hysterectomy operated due to genitourinary prolapse were recruited. Each patient was also evaluated for joint hypermobility.
APMIS
September 2008
Department of Pathology, Länsi-Pohja Central Hospital, Kemi, Finland.
Endometriosis, a relatively common disease generally affecting women in the reproductive age group, is mostly found in the pelvic organs. Although endometriosis is a benign disease, some malignant tumors have been reported to develop in endometriotic lesions, most commonly in the ovary. The relationship between endometriosis and malignancy is not well known, but the majority of endometriosis-associated ovarian malignancies are usually endometrioid adenocarcinomas and clear cell carcinomas.
View Article and Find Full Text PDFJ Asthma
October 2002
Department of Pulmonary Medicine, Länsi-Pohja Central Hospital, Kemi, Finland.
We have compared data from northern and southern Finland in a large epidemiological survey on respiratory conditions. The aim was to compare the prevalence of respiratory symptoms, asthma, and chronic bronchitis in northern and southern Finland. The study was a part of comparative studies in Finland, Estonia, and Sweden, the FinEsS studies.
View Article and Find Full Text PDFAllergy
February 2001
Department of Pulmonary Medicine, Länsi-Pohja Central Hospital, Kemi, Finland.
Background: According to previous studies, the prevalence of asthma has been lower in Finland than in other Nordic countries. In the present study, we assessed the prevalence of asthma and respiratory symptoms in northern Finland and calculated risk factors for these conditions.
Methods: In November 1995, 7937 randomly selected subjects, 20-69 years of age, in northern Finland were invited to participate in a postal questionnaire survey.
Duodecim
October 2000
Department of Pulmonary Medicine, Lansi-Pohja Central Hospital, Kemi, Finland.
Duodecim
October 2000
Lansi-Pohja Central Hospital, Division of Surgery, Kemi, Finland.